Related Experiment Video
Updated: Aug 23, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)
Sonali Batta1, Austinn C Miller2, Susuana Adjei2
1Texas A&M College of Medicine, Temple, Texas.
Abstract:
We present a case of erythema multiforme (EM) associated with a third (booster) dose of COVID-19 vaccination in a patient who had no cutaneous reactions to previous doses. To our knowledge, this is the first documented case of vaccine-associated EM occurring after a third/booster vaccination. Furthermore, our case emphasizes the need to remain vigilant for vaccine-associated EM in any patient recently vaccinated, regardless of whether previous vaccinations were administered without cutaneous reactions.
Related Concept Videos
Myocarditis III: Medical Management
Cross-reactivity
Vaccinations
Myocarditis II: Clinical Features and Diagnostic Tests
Allergic Reactions
Allergic Drug Reactions

